PhaseV raises $15M to optimize clinical trials with conventional machine learning | CTech

PhaseV raises $15M to optimize clinical trials with conventional machine learning |  CTech

PhaseV, which develops causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced Tuesday that it has raised $15 million in funding led by Viola Ventures and Exor Ventures, including participation from LionBird and a group of has gathered prominent angel investors. . A recent Deloitte study estimated the average cost of …

Read more